Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide in MALT lymphoma
NCT00923663Phase 2Unknown
- Sponsor
- Medical University of Vienna
- Start
- Jul 2009
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue, sponsored by Medical University of Vienna. Status: unknown.
02
Drugs
lenalidomide
03
Conditions
extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue
Beyond the preview
Go deeper on NCT00923663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00923663.